Whole body overexpression of PGC-1alpha has opposite effects on hepatic and muscle insulin sensitivity.

Type 2 diabetes is characterized by fasting hyperglycemia, secondary to hepatic insulin resistance and increased glucose production. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) is a transcriptional coactivator that is thought to control adaptive responses to physiological stimuli. In liver, PGC-1alpha expression is induced by fasting, and this effect promotes gluconeogenesis. To examine whether PGC-1alpha is involved in the pathogenesis of hepatic insulin resistance, we generated transgenic (TG) mice with whole body overexpression of human PGC-1alpha and evaluated glucose homeostasis with a euglycemic-hyperinsulinemic clamp. PGC-1alpha was moderately (approximately 2-fold) overexpressed in liver, skeletal muscle, brain, and heart of TG mice. In liver, PGC-1alpha overexpression resulted in increased expression of hepatocyte nuclear factor-4alpha and the gluconeogenic enzymes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase. PGC-1alpha overexpression caused hepatic insulin resistance, manifested by higher glucose production and diminished insulin suppression of gluconeogenesis. Paradoxically, PGC-1alpha overexpression improved muscle insulin sensitivity, as evidenced by elevated insulin-stimulated Akt phosphorylation and peripheral glucose disposal. Content of myoglobin and troponin I slow protein was increased in muscle of TG mice, indicating fiber-type switching. PGC-1alpha overexpression also led to lower reactive oxygen species production by mitochondria and reduced IKK/IkappaB signaling in muscle. Feeding a high-fat diet to TG mice eliminated the increased muscle insulin sensitivity. The dichotomous effect of PGC-1alpha overexpression in liver and muscle suggests that PGC-1alpha is a fuel gauge that couples energy demands (muscle) with the corresponding fuel supply (liver). Thus, under conditions of physiological stress (i.e., prolonged fast and exercise training), increased hepatic glucose production may help sustain glucose utilization in peripheral tissues.

[1]  B. Morley,et al.  A time course and dose-response study of the regulation of brain nicotinic receptors by dietary choline , 1987, Brain Research.

[2]  Xianlin Han,et al.  The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. , 2008, American journal of physiology. Heart and circulatory physiology.

[3]  C. Lee,et al.  Biochemical studies of skeletal muscle mitochondria. I. Microanalysis of cytochrome content, oxidative and phosphorylative activities of mammalian skeletal muscle mitochondria. , 1968, Archives of biochemistry and biophysics.

[4]  R. DeFronzo,et al.  Effect of Acute Exercise on AMPK Signaling in Skeletal Muscle of Subjects With Type 2 Diabetes , 2007, Diabetes.

[5]  M. Cataldi,et al.  Nitric oxide induces [Ca2+]i oscillations in pituitary GH3 cells: involvement of IDR and ERG K+ currents. , 2006, American journal of physiology. Cell physiology.

[6]  Ralph A. DeFronzo,et al.  Reduced Skeletal Muscle Inhibitor of κBβ Content Is Associated With Insulin Resistance in Subjects With Type 2 Diabetes: Reversal by Exercise Training , 2006 .

[7]  P. Puigserver,et al.  Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[9]  R. DeFronzo,et al.  Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.

[10]  Y. Tamura,et al.  Amelioration of glucose tolerance by hepatic inhibition of nuclear factor κB in db/db mice , 2006, Diabetologia.

[11]  Marc Montminy,et al.  PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3 , 2004, Nature Medicine.

[12]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[13]  N. Ruderman,et al.  Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and IκB-α , 2002 .

[14]  R. O’Doherty,et al.  Fatty Acid-induced Insulin Resistance in L6 Myotubes Is Prevented by Inhibition of Activation and Nuclear Localization of Nuclear Factor κB* , 2004, Journal of Biological Chemistry.

[15]  E. Kraegen,et al.  Development of Muscle Insulin Resistance After Liver Insulin Resistance in High-Fat–Fed Rats , 1991, Diabetes.

[16]  I. Nishino,et al.  Overexpression of Peroxisome Proliferator-Activated Receptor γ Co-Activator-1α Leads to Muscle Atrophy with Depletion of ATP , 2006 .

[17]  L. Nolte,et al.  Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC‐1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  G. Tamburrano,et al.  Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia , 1998, Diabetologia.

[19]  G. Shulman,et al.  Cellular mechanisms of insulin resistance in humans. , 1999, The American journal of cardiology.

[20]  G. Hotamisligil.  Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. , 2005, Diabetes.

[21]  Ralph A. DeFronzo,et al.  Metabolic and molecular basis of insulin resistance , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[22]  G. Hotamisligil,et al.  Role of Endoplasmic Reticulum Stress and c-Jun NH 2-Terminal Kinase Pathways in Inflammation and Origin of Obesity and Diabetes , 2005 .

[23]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[24]  N. Ruderman,et al.  Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. , 2002, Diabetes.

[25]  C. Schmitz‐Peiffer,et al.  Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with Palmitate* , 1999, The Journal of Biological Chemistry.

[26]  P. Puigserver,et al.  Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-α , 2005, International Journal of Obesity.

[27]  X. Busquets,et al.  NF-κB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight , 2004, Thorax.

[28]  Jiandie D. Lin,et al.  PGC-1β in the Regulation of Hepatic Glucose and Energy Metabolism* , 2003, Journal of Biological Chemistry.

[29]  W. Kraus,et al.  PGC-1α mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle , 2004 .

[30]  R. DeFronzo,et al.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. , 1985, The Journal of clinical investigation.

[31]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[32]  J. Dubé,et al.  Leptin, skeletal muscle lipids, and lipid-induced insulin resistance. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[33]  R. DeFronzo,et al.  Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus , 1982, Diabetologia.

[34]  Robert V Farese,et al.  Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. , 2007, Cell metabolism.

[35]  N. Ruderman,et al.  Enhanced Stimulation of Diacylglycerol and Lipid Synthesis by Insulin in Denervated Muscle: Altered Protein Kinase C Activity and Possible Link to Insulin Resistance , 1991, Diabetes.

[36]  Jiandie D. Lin,et al.  Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres , 2002, Nature.

[37]  F. Muller,et al.  Complex III Releases Superoxide to Both Sides of the Inner Mitochondrial Membrane* , 2004, Journal of Biological Chemistry.

[38]  J. Saffitz,et al.  Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. , 2000, The Journal of clinical investigation.

[39]  R. DeFronzo,et al.  Insulin Resistance is a Prominent Feature of Insulin-dependent Diabetes , 1982, Diabetes.

[40]  Henriette Pilegaard,et al.  Exercise induces transient transcriptional activation of the PGC‐1α gene in human skeletal muscle , 2003, The Journal of physiology.

[41]  N. Fujii,et al.  p38γ MAPK regulation of glucose transporter expression and glucose uptake in L6 myotubes and mouse skeletal muscle , 2004 .

[42]  J. Dubé,et al.  Diet-induced obesity and acute hyperlipidemia reduce IκBα levels in rat skeletal muscle in a fiber-type dependent manner , 2006 .

[43]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[44]  I. Tabata,et al.  cDNA Cloning and mRNA analysis of PGC-1 in epitrochlearis muscle in swimming-exercised rats. , 2000, Biochemical and biophysical research communications.

[45]  F. Liu,et al.  Peripheral Disruption of the Grb10 Gene Enhances Insulin Signaling and Sensitivity In Vivo , 2007, Molecular and Cellular Biology.

[46]  Marc Montminy,et al.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[47]  Bruce M. Spiegelman,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction , 2003, Nature.

[48]  R. DeFronzo,et al.  Pathogenesis of type 2 diabetes mellitus. , 2004, The Medical clinics of North America.

[49]  P. Puigserver,et al.  Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): Requirement for hepatocyte nuclear factor 4α in gluconeogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  P. Puigserver,et al.  A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.

[51]  R. Bergman.  New concepts in extracellular signaling for insulin action: the single gateway hypothesis. , 1997, Recent progress in hormone research.

[52]  E. Taylor,et al.  Endurance training increases skeletal muscle LKB1 and PGC-1alpha protein abundance: effects of time and intensity. , 2005, American journal of physiology. Endocrinology and metabolism.

[53]  B. Spiegelman,et al.  Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. , 2006, Endocrine reviews.